Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Amilcar F Cardona, Samuel E Wilson

Abstract

Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality among hospitalized patients and a major therapeutic challenge for clinicians. Although uncomplicated SSTIs are managed successfully on an outpatient basis, more serious infections extending to the subcutaneous tissue, fascia, or muscle require complex management. Early diagnosis, selection of appropriate antimicrobials, and timely surgical intervention are key to successful treatment. Surgical-site infections, an important category of SSTI, occur in approximately half a million patients in North America annually. SSTIs are also a potential source for life-threatening bacteremia and metastatic abscesses. Gram-positive organisms, such as Staphylococcus aureus and Streptococcus pyogenes, are the dominant organisms isolated early in the infectious process, whereas gram-negative organisms are found in chronic wounds. Methicillin-resistant S. aureus (MRSA) is a potential bloodstream invader that requires aggressive antimicrobial treatment and surgery. Recent concerns regarding vancomycin activity include heteroresistance in MRSA and increase in the minimum inhibitory concentrations (>1 or 2 µg/mL); however, alternative agents, such as telavancin...Continue Reading

References

Jan 1, 1985·Annals of Emergency Medicine·J L Llera, R C Levy
Jan 25, 1996·The New England Journal of Medicine·A L Bisno, D L Stevens
Nov 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Semel, H Goldin
Jun 11, 1999·BMJ : British Medical Journal·A DupuyS Bastuji-Garin
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E L MurphyB R Edlin
Jul 24, 2001·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Oct 10, 2002·Infectious Disease Clinics of North America·John R Ebright, Barbara Pieper
Jan 28, 2003·Diabetes Care·Baiju R Shah, Janet E Hux
Mar 27, 2003·American Journal of Surgery·Samuel Eric WilsonJon B Bruss
Dec 10, 2003·The Journal of Antimicrobial Chemotherapy·Lawrence J EronUNKNOWN Expert panel on managing skin and soft tissue infections
Jan 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James S Lewis, James H Jorgensen
Feb 23, 2005·Archives of Surgery·Daniel A AnayaEileen Bulger
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L M A J MullerG E H M Rutten
Jul 29, 2005·The Lancet Infectious Diseases·Donald C Vinh, John M Embil
Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Oct 3, 2006·The Journal of Antimicrobial Chemotherapy·Keith A RodvoldEvelyn J Ellis-Grosse
Mar 16, 2007·Public Health Reports·R Monina KlevensDenise M Cardo
Apr 5, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred C Tenover, Robert C Moellering
Jul 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jessica DarenbergBirgitta Henriques Normark
Oct 11, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Benjamin A LipskyMichael M Peng
Oct 13, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Deverick J AndersonKeith S Kaye
Dec 7, 2007·The Journal of Antimicrobial Chemotherapy·S J Dancer
Jan 9, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·John EdelsbergGerry Oster
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin E StryjewskiUNKNOWN Assessment of Telavancin in Complicated Skin and Skin-Structure Infections Study
May 15, 2008·The Annals of Pharmacotherapy·Shawn D Anderson, John G Gums
Aug 14, 2008·The Journal of Antimicrobial Chemotherapy·Alasdair P MacGowan
Sep 30, 2008·Scandinavian Journal of Infectious Diseases·Riad KhatibK Riederer
Oct 9, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Deverick J AndersonDeborah S Yokoe
Apr 9, 2009·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Vincent Ki, Coleman Rotstein
Aug 15, 2009·Nature Reviews. Microbiology·Henry F Chambers, Frank R Deleo
Oct 1, 2009·Emerging Infectious Diseases·John EdelsbergGerry Oster
Oct 24, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Marya D ZilberbergMarin H Kollef
Oct 29, 2009·Surgical Infections·Addison K MayUNKNOWN Surgical Infection Society
Dec 25, 2009·Pharmacotherapy·Michael T Guskey, Brian T Tsuji
Jun 25, 2010·American Journal of Surgery·Derek W MeeksLillian S Kao

❮ Previous
Next ❯

Citations

Sep 1, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christian E Sandrock, Andrew F Shorr
Sep 1, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Keith A Rodvold
Apr 17, 2016·Internal and Emergency Medicine·Marco FalconeFrancesco Violi
May 8, 2016·Peptides·Camilla BjörnJoakim Håkansson
Oct 25, 2016·PloS One·Jamal ChauhanErik P H de Leeuw
Jan 31, 2017·Current Opinion in Infectious Diseases·Garyphallia PoulakouSotirios Tsiodras
Apr 14, 2017·The Nurse Practitioner·Allison M BellKayla R Stover
Aug 29, 2018·The Nurse Practitioner·Allison M BellKayla R Stover
Jun 14, 2019·Frontiers in Public Health·Etaf HadyehZiad Abdeen
Jun 30, 2019·Journal of Burn Care & Research : Official Publication of the American Burn Association·Joshua M GrolmanKristo Nuutila
Aug 1, 2020·Frontiers in Cellular and Infection Microbiology·Malgorzata E MnichNina M van Sorge
May 8, 2020·Toxicology Mechanisms and Methods·Jayabal PrakashGopinath Devanand Venkatasubbu
Jun 14, 2019·Frontiers in Cellular and Infection Microbiology·Joakim HåkanssonMargit Mahlapuu
Aug 30, 2020·International Journal of Molecular Sciences·Magdalena StolarskaLukasz Sobotta
Apr 13, 2018·Frontiers in Pharmacology·Anja PfalzgraffGünther Weindl
Sep 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Irina NegutAlexandru Mihai Grumezescu
Aug 18, 2020·BioMed Research International·Jing-Chun ZhaoJia-Ao Yu
Oct 14, 2020·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Ayça Bal-ÖztürkEmine Alarçin
Aug 25, 2020·The Journal of Bone and Joint Surgery. American Volume·Chang Ho ShinWon Joon Yoo
Dec 17, 2018·Carbohydrate Polymers·Itzel Rubio-ElizaldeAna B Castro-Ceseña
Apr 14, 2020·Materials Science & Engineering. C, Materials for Biological Applications·Jinke YangGareth R Williams
Dec 1, 2020·Ultrasound in Medicine & Biology·Thomas J MatulaWayne Monsky
Jun 25, 2020·Current Drug Targets·Hongmin SunDavid W Anderson
Sep 23, 2019·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Selenia TernulloNataša Škalko-Basnet
Jan 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cassidy ScottChristian Lehmann
Oct 22, 2020·The Journal of Bone and Joint Surgery. American Volume·Chang Ho ShinWon Joon Yoo
May 21, 2021·Biomaterials Science·Zejun XuJun Wu
May 28, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Islam M AdelNermeen A Elkasabgy
Jul 13, 2021·Bioorganic & Medicinal Chemistry Letters·Lokadi Pierre Luhata, Toyonobu Usuki
Jul 22, 2021·ACS Applied Materials & Interfaces·Yangzhouyun XieXingyu Jiang
Dec 8, 2020·ACS Applied Materials & Interfaces·Simona LencovaKamila Zdenkova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Keith A Rodvold, Kevin W McConeghy
The American Journal of the Medical Sciences
Justin B UseryTimothy H Self
The Cochrane Database of Systematic Reviews
Jirong YueGuan J Liu
© 2021 Meta ULC. All rights reserved